Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids
Authors:
Open Access
- 15 August 2025
- journal article
- Published by Elsevier in Stem Cell Reports
- Vol. 20 (9) , 102601
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Clinical Research Center
- National Natural Science Foundation of China (2024CSJZN0600)
- National Natural Science Foundation of China (YDZX20233100001002)
- National Natural Science Foundation of China (92168107)
- National Natural Science Foundation of China (32130035)
- National Key Research and Development Program of China
- Shanghai Science and Technology Development Foundation
- ShanghaiTech University
- Key Technologies Research and Development Program (2021ZD0202500)
- Key Technologies Research and Development Program (2024YFA1108000)
This publication has 42 references indexed in Scilit:
- Cerebral organoids derived from patients with Alzheimer’s disease with PSEN1/2 mutations have defective tissue patterning and altered developmentCell Reports, 2023
- Human microglial state dynamics in Alzheimer’s disease progressionCell, 2023
- Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer’s disease pathologyCell, 2023
- Mechanism of M2 macrophages modulating astrocyte polarization through the TGF-β/PI3K/Akt pathwayImmunology Letters, 2023
- Deletion of Small GTPase H-Ras Rescues Memory Deficits and Reduces Amyloid Plaque-Associated Dendritic Spine Loss in Transgenic Alzheimer’s MiceMolecular Neurobiology, 2022
- Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum ExposureAdvanced Science, 2021
- A new insight into thymosin β4, a promising therapeutic approach for neurodegenerative disordersJournal of Cellular Physiology, 2019
- Probing human brain evolution and development in organoidsCurrent Opinion in Cell Biology, 2017
- Small heat shock proteins inhibit amyloid-β protein aggregation and cerebrovascular amyloid-β protein toxicityBrain Research, 2006
- The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult miceExperimental Neurology, 2004